nature.com

Fatty acid oxidation is a dominant bioenergetic pathway in prostate cancer - Prostate Cancer and Prostatic Diseases

  • ️Liu, Y
  • ️Tue May 09 2006

  • Warburg O . Respiratory impairment in cancer cells. Science 1956; 124: 269–270.

    CAS  PubMed  Google Scholar 

  • Burger C, Wick M, Brusselback S, Muller R . Differential induction of metabolic genes after mitogen stimulation and during normal cell cycle progression. J Cell Sci 1994; 107: 241–252.

    PubMed  Google Scholar 

  • Waki A, Kato H, Yano R . The importance of glucose transport activity as the rate-limiting step of 2-deoxyglucose uptake in tumor cells in vitro. Nucl Med Biol 1998; 25: 593–597.

    Article  CAS  Google Scholar 

  • Avril N, Menzel M, Dose J . GLUT1 expression in tissue and F18-FDG uptake. J Nucl Med 2004; 45: 930–932.

    CAS  PubMed  Google Scholar 

  • Chung JH, Cho KJ, Lee SS, Baek HJ, Park JH, Cheon GJ et al. Overexpression of GLUT1 in lymphoid follicles correlates with false-positive F18-FDG results in lung cancer staging. J Nucl Med 2004; 45: 999–1003.

    CAS  PubMed  Google Scholar 

  • Medina RA, Owen GI . Glucose transporters: expression, regulation and cancer. Biol Res 2002; 35: 9–26.

    Article  CAS  Google Scholar 

  • Smith TA . Facilitative glucose transporter expression in human cancer tissue. Br J Biomed Sci 1999; 56: 285–292.

    CAS  PubMed  Google Scholar 

  • Effert PJ, Bares R, Handt S, Wolff JM, Bull U, Jakse G et al. Metabolic imaging of untreated prostate cancer by positron emission tomography with 18F-FDG. J Urol 1996; 155: 994–998.

    Article  CAS  Google Scholar 

  • Hofer C, Laubenbacker C, Block T, Braul J, Hartung R, Schwaiger M . FDG-PET is useless for the detection of local recurrence after radical prostatectomy. Eur Urol 1999; 36: 31–35.

    Article  CAS  Google Scholar 

  • Candler JD, Williams ED, Slavin JL, Best JD, Rogers S . Expression and localization of GLUT1 and GLUT12 in prostate carcinoma. Cancer 2003; 97: 2035–2042.

    Article  Google Scholar 

  • Singh G, Lakkis CL, Laucirica R, Epner DE . Regulation of prostate cell division by glucose. J Cell Physiol 1999; 180: 431–438.

    Article  CAS  Google Scholar 

  • Legaspi A, Jeevanandam M, Starnes HF . Whole body lipid and energy metabolism in the cancer patient. Metabolism 1987; 36: 958–963.

    Article  CAS  Google Scholar 

  • Hyltander A . Elevated energy expenditure in cancer patients with solid tumours. Eur J Cancer 1991; 27: 9–15.

    Article  CAS  Google Scholar 

  • Russell ST, Tisdale MJ . Effect of a tumor-derived lipid-mobilising factor on glucose and lipid metabolism in vivo. Br. J Cancer 2002; 87: 580–584.

    Article  CAS  Google Scholar 

  • Faergeman NJ, Knudsen J . Role of long-chain fatty acyl-CoA esters in the regulation of metabolism and in cell signaling. Biochem J 1997; 323: 1–12.

    Article  CAS  Google Scholar 

  • Tang DG, La E, Kern J, Kehrer JP . Fatty acid oxidation and signaling in apoptosis. Biol Chem 2002; 383: 425–442.

    Article  CAS  Google Scholar 

  • Baron A, Migita T, Tang D, Loda M . Fatty acid synthase: a metabolic oncogene in prostate cancer? J Cell Biochem 2004; 91: 47–53.

    Article  CAS  Google Scholar 

  • Epstein JI, Carmichael M, Partin AW . Fatty acid synthase as an independent predictor of pathologic state in adenocarcinoma of the prostate. Urology 1995; 45: 81–86.

    Article  CAS  Google Scholar 

  • Rossi S, Graner E, Febbo P, Weinstein L, Bhattacharya N, Onody T et al. Fatty acid synthase expression defines distinct molecular signatures in prostate cancer. Mol Cancer Res 2003; 1: 707–715.

    CAS  PubMed  Google Scholar 

  • Pizer ES, Chrest FJ, DiGiuseppe JA, Han WF . Pharmacological inhibitors of mammalian fatty acid synthase suppress DNA replication and induce apoptosis in tumor cell lines. Cancer Res 1998; 58: 4611–4615.

    CAS  PubMed  Google Scholar 

  • Li JN, Gorospe M, Chrest FJ, Kumaravel TS . Pharmacological inhibition of fatty acid synthase activity produces both cytostatic and cytotoxic effects modulated by p53. Cancer Res 2001; 61: 1493–1499.

    CAS  PubMed  Google Scholar 

  • De Schrijver E, Brusselmans K, Heyns W, Verhoeven G, Swinnen JV . RNA interference-mediated silencing of the fatty acid synthase gene attenuates growth and induces morphological changes and apoptosis of LNCaP prostate cancer cells. Cancer Res 2003; 63: 3799–3804.

    CAS  PubMed  Google Scholar 

  • Moore S, Knudsen B, True LD, Hawley S, Etzioni R, Wade C et al. Loss of stearoyl-CoA desaturase expression is a frequent event in prostate carcinoma. Int J cancer 2005; 114: 563–571.

    Article  CAS  Google Scholar 

  • Ntambi JM, Miyazaki M, Stoehr JP . Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity. Proc Natl Acad Sci USA 2002; 99: 11482–11486.

    Article  CAS  Google Scholar 

  • Swinnen JV, Roskams T, Joniau S, Van Poppel H, Oyen R, Baert L et al. Overexpression of fatty acid synthase is an early and common event in the development of prostate cancer. Int J Cancer 2002; 98: 19–22.

    Article  CAS  Google Scholar 

  • Wanders RJ, Vreken P, den Boer ME, Wilburg FA . Disorders of mitochondrial fatty acyl-CoA beta-oxidation. J Inherit Metab Dis 1999; 22: 442–487.

    Article  CAS  Google Scholar 

  • Seedorf U, Brysch P, Engel T, Schrage K, Assmann G . Sterol carrier protein X is peroxisomal 3-oxoacyl coenzyme A thiolase with intrinsic sterol carrier and lipid transfer activity. J Biol Chem 1994; 269: 21277–21283.

    CAS  PubMed  Google Scholar 

  • Zha S, Ferdinandusse S, Hicks JL, Isaacs WB . Peroxisomal branched chain fatty acid beta-oxidation pathway is upregulated in prostate cancer. Prostate 2005; 63: 316–323.

    Article  CAS  Google Scholar 

  • Jiang Z, Woda BA, Rock KL, Xu Y, Savas L, Khan A et al. A new molecular marker for the detection of prostate carcinoma. Am J Surg Pathol 2001; 25: 1397–1404.

    Article  CAS  Google Scholar 

  • Luo J, Zha S, Gage WR . Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer. Cancer Res 2002; 62: 2220–2226.

    CAS  PubMed  Google Scholar 

  • Rubin MA, Zhou M, Dhanasekaran SM, Varambally S, Bareette TR, Sanda MG et al. Alpha-methylacyl-coenzyme A racemase as a tissue biomarker for prostate cancer. JAMA 2002; 287: 1662–1670.

    Article  CAS  Google Scholar 

  • Kumar-Sinha C, Shah RB, Laxman B, Harwood J, Schmitz W, Conzelmann E et al. Elevated alpha-methylacyl-CoA racemase enzymatic activity in prostate cancer. Am J Pathol 2004; 164: 787–793.

    Article  CAS  Google Scholar 

  • Costello LC, Franklin RB, Narayan P . Citrate in the diagnosis of prostate cancer. Prostate 1999; 38: 237–245.

    Article  CAS  Google Scholar 

  • Costello LC, Franklin RB . Citrate metabolism of normal and malignant prostate epithelial cells. Urology 1997; 50: 3–12.

    Article  CAS  Google Scholar 

  • Costello LC, Feng P, Tan M, Franklin RB . Role of zinc in the pathogenesis and treatment of prostate cancer: critical issue to resolve. Prostate Cancer Prostate Dis 2004; 7: 11–117.

    Article  Google Scholar 

  • Kurhanewicz J, Vigneron DB, Hricak H, Narayan P, Carrol P, Nelson SJ et al. Three dimensional hydrogen-1 MR spectroscopic imaging of the in situ human prostate with high spatial resolution. Radiology 1996; 198: 795–805.

    Article  CAS  Google Scholar 

  • Cooper JE, Farid I . The role of citric acid in the physiology of the prostate: lactic/citrate in benign and malignant prostatic homogenates as an index of prostate malignancy. J Urol 1964; 92: 533–536.

    Article  CAS  Google Scholar 

  • Costello LC, Liu Y, Franklin RB . Zinc inhibition of mitochondrial aconitase and its importance in citrate metabolism of prostate epithelial cells. J Biol Chem 1997; 272: 28875–28881.

    Article  CAS  Google Scholar 

  • Costello LC, Franklin RB . The intermediary metabolism of the prostate: a key to understanding the pathogenesis and progression of prostate malignancy. Oncology 2000; 59: 269–282.

    Article  CAS  Google Scholar 

  • Fleshner N, Bagnell PS, Klotz L, Venkateswaran V . Dietary fat and prostate cancer. J Urol 2004; 171: S19–S24.

    CAS  PubMed  Google Scholar 

  • Pour PM, Croot K, Kazakoff K, Anderson K, Schally AV . Effects of high-fat diet on the patterns of prostatic cancer induced in rats by N-nitrosobis (2-oxopropyl) amine and testosterone. Cancer Res 1991; 51: 4757.

    CAS  PubMed  Google Scholar 

  • Wang Y, Corr JG, Thaler HT, Tao Y, Fair WR, Heston WD . Decreased growth of established human prostate LNCaP tumors in nude mice fed a low-fat diet. J Natl Cancer Inst 1995; 87: 1261–1456.

    Article  Google Scholar 

  • Hill P, Wynder EL, Garbaczewski L . Diet and urinary steroids in black and white North American men and black South African men. Cancer Res 1979; 39: 5101–5108.

    CAS  PubMed  Google Scholar 

  • Dorgan JF, Judd JT, Longcope C, Brown C, Schatzkin A, Clevidence BA et al. Effects of dietary fat and fiber on plasma and urine androgens and estrogens in men: a controlled feeding study. Am J Clin Nutr 1996; 64: 850–857.

    Article  CAS  Google Scholar 

  • Sonn GA, Aronson W, Litwin MS . Impact of Diet on prostate cancer: a review. Prostate Cancer Prostatic Dis 2005; 8: 304–310.

    Article  CAS  Google Scholar 

  • Ngo TH . Insulin-like growth factor I (IGF-I) and IGF binding protein-1 modulate prostate cancer cell growth and apoptosis: possible mediators for the effect of diet and exercise on cancer cell survival. Endocrinology 2003; 144: 2319–2324.

    Article  CAS  Google Scholar 

  • Prentice RL, Sheppard L . Dietary fat and cancer: consistency of the epidemiologic data, and disease prevention that may follow from a practical reduction in fat consumption. Cancer Causes Control 1990; 1: 81–88.

    Article  CAS  Google Scholar 

  • Chen YC, Chiang CI, Lin RS, Pu YS, Lai MK, Sung FC et al. Diet, vegetarian food and prostate carcinoma among men in Taiwan. Br J Cancer 2005; 93: 1057–1061.

    Article  CAS  Google Scholar 

  • Oyama N, Miller TR, Dehdashti F . C11-acetate PET imaging of prostate cancer: detection of recurrent disease at PSA relapse. J Nucl Med 2003; 44: 549–555.

    CAS  PubMed  Google Scholar 

  • Dimitrakopoulou-Strauss A, Strauss L . PET imaging of prostate cancer with C11-acetate. J Nucl Med 2003; 44: 556–558.

    PubMed  Google Scholar